Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hansch

Showing results (91-100 of 197) with videos related to

Pageof 20
Sort By:
Journal of Medicinal Chemistry|January 1, 1977
Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidinesC Hansch, J Y Fukunaga, P Y Jow
Molecular Pharmacology|May 1, 1985
A quantitative structure-activity relationship and molecular graphics study of carbonic anhydrase inhibitorsC Hansch, J McClarin, T Klein, et al.
Journal of Medicinal Chemistry|April 1, 1977
Quantitative structure-activity relationships of chymotrypsin. On the predictive value of correlation equationsC Grieco, C Silipo, A Vittoria, et al.
Journal of Medicinal Chemistry|September 1, 1975
Structure-activity relationship in synthetic fibrinolytics. 2-PhenethynylcyclopropanecarboxylatesM Yoshimoto, K N von Kaulla, C Hansch
Journal of Medicinal Chemistry|May 1, 1981
Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidinesR L Li, S W Dietrich, C Hansch
Mutation Research|November 14, 1997
QSAR treatment of multiple toxicities: the mutagenicity and cytotoxicity of quinolinesC J Smith, C Hansch, M J Morton
Journal of Medicinal Chemistry|May 1, 1976
Inhibition of dihydrofolate reductase. Structure-activity correlations of quinazolinesJ Y Fukunaga, C Hansch, E E Steller
Journal of Medicinal Chemistry|May 1, 1981
Inhibition of bovine and rat liver dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(4-substituted-phenyl)-s-triazinesC Hansch, S W Dietrich, J Y Fukunaga
Archives of Biochemistry and Biophysics|May 1, 1979
Inhibition of chymotrypsin by alkyl phosphonates: a quantitative structure-activity analysisC Silipo, C Hansch, C Grieco, et al.
Journal of Medicinal Chemistry|July 1, 1990
Structure-activity relationships of antineoplastic agents in multidrug resistanceC D Selassie, C Hansch, T A Khwaja
Pageof 20

Showing results (91-100 of 197) with videos related to

Sort By:
Pageof 20
Journal of Medicinal Chemistry|January 1, 1977
Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidinesC Hansch, J Y Fukunaga, P Y Jow
Molecular Pharmacology|May 1, 1985
A quantitative structure-activity relationship and molecular graphics study of carbonic anhydrase inhibitorsC Hansch, J McClarin, T Klein, et al.
Journal of Medicinal Chemistry|April 1, 1977
Quantitative structure-activity relationships of chymotrypsin. On the predictive value of correlation equationsC Grieco, C Silipo, A Vittoria, et al.
Journal of Medicinal Chemistry|September 1, 1975
Structure-activity relationship in synthetic fibrinolytics. 2-PhenethynylcyclopropanecarboxylatesM Yoshimoto, K N von Kaulla, C Hansch
Journal of Medicinal Chemistry|May 1, 1981
Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidinesR L Li, S W Dietrich, C Hansch
Mutation Research|November 14, 1997
QSAR treatment of multiple toxicities: the mutagenicity and cytotoxicity of quinolinesC J Smith, C Hansch, M J Morton
Journal of Medicinal Chemistry|May 1, 1976
Inhibition of dihydrofolate reductase. Structure-activity correlations of quinazolinesJ Y Fukunaga, C Hansch, E E Steller
Journal of Medicinal Chemistry|May 1, 1981
Inhibition of bovine and rat liver dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(4-substituted-phenyl)-s-triazinesC Hansch, S W Dietrich, J Y Fukunaga
Archives of Biochemistry and Biophysics|May 1, 1979
Inhibition of chymotrypsin by alkyl phosphonates: a quantitative structure-activity analysisC Silipo, C Hansch, C Grieco, et al.
Journal of Medicinal Chemistry|July 1, 1990
Structure-activity relationships of antineoplastic agents in multidrug resistanceC D Selassie, C Hansch, T A Khwaja
Pageof 20